Regulation And Legal
Aurobindo Pharma Unit Gets US FDA Warning Letter
Eugia Pharma Specialities Ltd, a wholly-owned subsidiary of Aurobindo Pharma, received a US FDA Warning Letter for its Unit I formulation manufacturing facility.
The facility contributes approximately
